These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32883024)

  • 1. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
    Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.
    Park J; Shim JK; Kang JH; Choi J; Chang JH; Kim SY; Kang SG
    Neuro Oncol; 2018 Jun; 20(7):954-965. PubMed ID: 29294080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC.
    Lee S; Lee JS; Seo J; Lee SH; Kang JH; Song J; Kim SY
    Sci Rep; 2018 Oct; 8(1):15707. PubMed ID: 30356107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
    Kang JH; Lee SH; Lee JS; Nam B; Seong TW; Son J; Jang H; Hong KM; Lee C; Kim SY
    Oncotarget; 2016 Aug; 7(31):49397-49410. PubMed ID: 27384481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer.
    Masoud R; Reyes-Castellanos G; Lac S; Garcia J; Dou S; Shintu L; Abdel Hadi N; Gicquel T; El Kaoutari A; Diémé B; Tranchida F; Cormareche L; Borge L; Gayet O; Pasquier E; Dusetti N; Iovanna J; Carrier A
    Cell Rep Med; 2020 Nov; 1(8):100143. PubMed ID: 33294863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment.
    Bosc C; Selak MA; Sarry JE
    Cell Metab; 2017 Nov; 26(5):705-707. PubMed ID: 29117545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres.
    Park HH; Park J; Cho HJ; Shim JK; Moon JH; Kim EH; Chang JH; Kim SY; Kang SG
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33429981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.
    Al Assi A; Posty S; Lamarche F; Chebel A; Guitton J; Cottet-Rousselle C; Prudent R; Lafanechère L; Giraud S; Dallemagne P; Suzanne P; Verney A; Genestier L; Castets M; Fontaine E; Billaud M; Cordier-Bussat M
    Cell Death Dis; 2024 May; 15(5):311. PubMed ID: 38697987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
    Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z
    Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
    Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin.
    Zhong J; Sun P; Xu N; Liao M; Xu C; Ding Y; Cai J; Zhang Y; Xie W
    Biochem Pharmacol; 2020 May; 175():113856. PubMed ID: 32061772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics.
    Kriel J; Müller-Nedebock K; Maarman G; Mbizana S; Ojuka E; Klumperman B; Loos B
    Sci Rep; 2018 Jul; 8(1):10348. PubMed ID: 29985441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugging OXPHOS Dependency in Cancer.
    Cancer Discov; 2019 Aug; 9(8):OF10. PubMed ID: 31186236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
    Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
    Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
    Sui X; Chen R; Wang Z; Huang Z; Kong N; Zhang M; Han W; Lou F; Yang J; Zhang Q; Wang X; He C; Pan H
    Cell Death Dis; 2013 Oct; 4(10):e838. PubMed ID: 24113172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol derivative 9bw suppresses growth of neuroblastoma cells by inhibiting oxidative phosphorylation.
    Nagasaki-Maeoka E; Ikeda K; Takayama KI; Hirano T; Ishizuka Y; Koshinaga T; Tsukune N; Takayama T; Inoue S; Fujiwara K
    Cancer Sci; 2020 Aug; 111(8):2943-2953. PubMed ID: 32495467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
    Totten SP; Im YK; Cepeda Cañedo E; Najyb O; Nguyen A; Hébert S; Ahn R; Lewis K; Lebeau B; La Selva R; Sabourin V; Martínez C; Savage P; Kuasne H; Avizonis D; Santos Martínez N; Chabot C; Aguilar-Mahecha A; Goulet ML; Dankner M; Witcher M; Petrecca K; Basik M; Pollak M; Topisirovic I; Lin R; Siegel PM; Kleinman CL; Park M; St-Pierre J; Ursini-Siegel J
    Nat Commun; 2021 Jun; 12(1):3299. PubMed ID: 34083537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy for poisoning cancer cell metabolism: Inhibition of oxidative phosphorylation coupled to anaplerotic saturation.
    Sica V; Bravo-San Pedro JM; Kroemer G
    Int Rev Cell Mol Biol; 2019; 347():27-37. PubMed ID: 31451215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.